Medisun Holdings Limited has partnered with the Mayo Clinic in Rochester, Minnesota to jointly establish an affiliated hospital network system in Hong Kong and Mainland China.
Mayo Clinic ranked #1 in the United States
Medisun’s NK cell technology provides us with treatment option for cancer. The NK cell technology is currently clinically used to treat cancer patients at Medisun’s network clinical facilities. We may seek to commercialize the NK cell technology and/or pursue strategic collaboration partnerships with other companies or clinical facilities.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.